-
Strategic Growth: Piramal Pharma Limited Completes Acquisition of Majority Stake in Yapan Bio
Expanding Capabilities in the Biologics Sector Piramal Pharma Limited (PPL) has officially announced the successful completion of its acquisition of a majority stake in Yapan Bio Private Limited. This strategic move marks a significant milestone in Piramal’s ongoing effort to broaden its service offerings within the rapidly evolving biologics and advanced therapy medicinal products (ATMPs)…
-
Sanofi’s $2.2 Billion Bet: What Their Acquisition of an HBV Vaccine Maker Means for Global Health
NASDAQ: $SNY In a move that sent ripples through the pharmaceutical landscape, Sanofi recently announced its acquisition of a Hepatitis B (HBV) vaccine maker for a staggering $2.2 billion. This strategic purchase, detailed in a recent article from Pharmaceutical Technology, isn’t just a financial transaction; it represents a significant investment in global public health and…